183 related articles for article (PubMed ID: 17705290)
1. Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration.
Rite I; Argüelles S; Venero JL; García-Rodriguez S; Ayala A; Cano J; Machado A
J Neurosci Res; 2007 Dec; 85(16):3607-18. PubMed ID: 17705290
[TBL] [Abstract][Full Text] [Related]
2. Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease.
Argüelles S; Venero JL; García-Rodriguez S; Tomas-Camardiel M; Ayala A; Cano J; Machado A
Neurochem Int; 2010 Oct; 57(3):227-34. PubMed ID: 20553985
[TBL] [Abstract][Full Text] [Related]
3. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
Iwata SI; Nomoto M; Fukuda T
Synapse; 2001 Jan; 39(1):16-22. PubMed ID: 11071705
[TBL] [Abstract][Full Text] [Related]
4. Biochemical alteration in cerebrospinal fluid precedes behavioral deficits in Parkinsonian rats induced by 6-hydroxydopamine.
Lin JW; Shih CM; Chen YC; Lin CM; Tsai JT; Chiang YH; Shih R; Chiu PL; Hung KS; Yeh YS; Wei L; Chiu WT; Yang LY
Surg Neurol; 2009 Dec; 72 Suppl 2():S55-65; discussion S65. PubMed ID: 19944827
[TBL] [Abstract][Full Text] [Related]
5. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
Sedaghat K; Finkelstein DI; Gundlach AL
Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
[TBL] [Abstract][Full Text] [Related]
6. A proteomic approach in the study of an animal model of Parkinson's disease.
De Iuliis A; Grigoletto J; Recchia A; Giusti P; Arslan P
Clin Chim Acta; 2005 Jul; 357(2):202-9. PubMed ID: 15946658
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients.
Jin T; Hu LS; Chang M; Wu J; Winblad B; Zhu J
Eur J Neurol; 2007 May; 14(5):563-8. PubMed ID: 17437617
[TBL] [Abstract][Full Text] [Related]
8. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
McArthur S; Murray HE; Dhankot A; Dexter DT; Gillies GE
J Neurochem; 2007 Feb; 100(3):678-92. PubMed ID: 17116232
[TBL] [Abstract][Full Text] [Related]
9. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
[TBL] [Abstract][Full Text] [Related]
10. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
11. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra.
Jiang H; Song N; Wang J; Ren LY; Xie JX
Neurochem Int; 2007 Jul; 51(1):32-6. PubMed ID: 17490790
[TBL] [Abstract][Full Text] [Related]
12. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
[TBL] [Abstract][Full Text] [Related]
13. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
Yasuda T; Fukuda-Tani M; Nihira T; Wada K; Hattori N; Mizuno Y; Mochizuki H
Exp Neurol; 2007 Aug; 206(2):308-17. PubMed ID: 17604022
[TBL] [Abstract][Full Text] [Related]
14. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
Mogi M; Kondo T; Mizuno Y; Nagatsu T
Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
[TBL] [Abstract][Full Text] [Related]
15. An organotypic culture model to study nigro-striatal degeneration.
Cavaliere F; Vicente ES; Matute C
J Neurosci Methods; 2010 May; 188(2):205-12. PubMed ID: 20153372
[TBL] [Abstract][Full Text] [Related]
16. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
Belluscio MA; Riquelme LA; Murer MG
Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
[TBL] [Abstract][Full Text] [Related]
17. Exogenous l-DOPA induce no dopamine immuno-reactivity in striatal astroglias and microglias of adult rats with extensive nigro-striatal dopaminergic denervation.
Maeda T; Nagata K; Yoshida Y
Neurosci Lett; 2008 Mar; 433(3):255-8. PubMed ID: 18255227
[TBL] [Abstract][Full Text] [Related]
18. Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease.
Tassorelli C; Armentero MT; Greco R; Fancellu R; Sandrini G; Nappi G; Blandini F
Brain Res; 2007 Oct; 1176():53-61. PubMed ID: 17884026
[TBL] [Abstract][Full Text] [Related]
19. Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease.
Boska MD; Hasan KM; Kibuule D; Banerjee R; McIntyre E; Nelson JA; Hahn T; Gendelman HE; Mosley RL
Neurobiol Dis; 2007 Jun; 26(3):590-6. PubMed ID: 17428671
[TBL] [Abstract][Full Text] [Related]
20. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
Liu B; Dluzen DE
Synapse; 2006 Oct; 60(5):354-61. PubMed ID: 16838362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]